Number of Clinical Trial (C.T) and Patient(Pt)

Number of Clinical Trial (C.T) and Patient(Pt)

**Cerebrovascular Disease**
Compared with	beginning of Period	Conclusion of Period	No. C.T.	No. Pt
Placebo	1973	1988	15	1916
calcium hopantenate	1984	1986	9	1413
ifenprodil tartrate	1979	1982	8	1049
nicardipine hydrochloride	1983	1991	5	818
pentoxifylline	1978	1979	4	744
dihydroergotoxine mesilate	1978	1987	3	598
pyrithioxine dihydrochloride	1974	1978	3	413
dilazep dihydrochloride	1984	1984	2	323
idebenone	1990	1990	2	296
others			3	384

**Hypertension**
Compared with	beginning of Period	Conclusion of Period	No. C.T.	No. Pt
propanolol hydrochloride	1979	1986	14	1617
nicardipine hydrochloride	1985	1989	8	1005
pindolol	1978	1983	9	848
captopril	1983	1986	6	831
enalapril malrate	1988	1989	4	497
bunitrolol hydrochloride	1985	1985	4	408
hydralazine hydrochloride	1979	1980	4	319
labetalol hydrochloride	1984	1984	2	182
placebo	1973	1979	2	131
others			11	1364

**Peptic Ulcers**
Compared with	beginning of Period	Conclusion of Period	No. C.T.	No. Pt
gefarnate	1974	1981	7	1223
cetraxate hydrochloride	1982	1987	7	1073
proglumide	1981	1983	3	413
placebo	1974	1978	2	235
cimetidine	1985	1985	1	141

**Schizophrnia**
Compared with	No. C.T.	No. Pt
haloperidol	10	847
sulpiride	4	266
placebo	2	247
clorpromazine dihydrochloride	3	220
perphenazine	1	116
chlomazine（1985）	1	35

**Neurosis**
Compared with	No. C.T.	No. Pt
haloperidol	10	847
dizepam	17	1296
placebo	12	855
mexazolam	1	71

**Depression**
Compared with	No. C.T.	No. Pt
haloperidol	10	847
imiprmine hydrochloride	13	903
amitriptyline hydrochloride	7	488
mianserin hydrochloride	1	51

**Arrhythmia**
Compared with	No. C.T.	No. Pt
haloperidol	10	847
disopyramide	13	686
others	3	176

**Osteoporosis**
Compared with	No. C.T.	No. Pt
haloperidol	10	847
placebo	7	860
alfacalcidol	3	703

**Chronic Hepatitis**
Compared with	No. C.T.	No. Pt
haloperidol	10	847
placebo	7	996
others	2	231

back to Controller Committee (E) home page
back to Controller Committee